First Time Loading...

Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 148.95 EUR -0.67% Market Closed
Updated: May 1, 2024

Merck KGaA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merck KGaA
Revenue Peer Comparison

Comparables:
ATAI
BAYN
93M1
DMP
PSG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Merck KGaA
XETRA:MRK
Revenue
€21B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
ATAI Life Sciences NV
NASDAQ:ATAI
Revenue
$314k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Revenue
€47.6B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
2%
MPH Health Care AG
XETRA:93M1
Revenue
€37.4k
CAGR 3-Years
-5%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Revenue
€1.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Revenue
€85.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Merck KGaA's Revenue?
Revenue
21B EUR

Based on the financial report for Dec 31, 2023, Merck KGaA's Revenue amounts to 21B EUR.

What is Merck KGaA's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Merck KGaA have been 6% over the past three years , 7% over the past five years , and 7% over the past ten years .